Aptose Biosciences Board Approved 1:15 Reverse Stock Split Effective May 24, 2023
Portfolio Pulse from Charles Gross
Aptose Biosciences' board has approved a 1:15 reverse stock split, effective May 24, 2023. This move aims to increase the stock price and reduce the number of outstanding shares.

May 23, 2023 | 9:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aptose Biosciences' 1:15 reverse stock split will increase the stock price and reduce the number of outstanding shares, potentially attracting more investors.
A reverse stock split reduces the number of outstanding shares and increases the stock price, making the stock more attractive to investors. This can lead to increased demand and a potential short-term positive impact on the stock price. However, the long-term impact will depend on the company's performance and market conditions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100